INTRAVENOUS injection of bacillus Calmette-Guerin (B.C.G.) organisms suppresses growth of artificial pulmonary metastases of rat sarcomata, produced by intravenous injection of tumour cells (Baldwin and Pimm, 1973a) . In addition, spontaneous pulmonary metastases, appearing after surgical removal of subcutaneous growths of a transplanted rat epithelioma, are restricted by intravenously administered B.C.G. (Baldwin and Pimm, 1973b) . This type of growth suppression is probably a reflection of a B.C.G. mediated granulomatous response at the site oftumour metastasis following B.C.G. entry into lung tissue and may be comparable with the restriction of tumour growth when cells are injected subcutaneously or intradermally in contact with B.C.G. (Baldwin and Pimm, 1971, 1973c;  Bartlett, Zbar and Rapp, 1972; Zbar, Bernstein and Rapp 1971) .
So far, B.C.G. treatment of pulmonary metastasis has been evaluated with transplanted animal tumours; the objective of the present experimental studies was to assess the influence of intravenously administered B.C.G. on the development of metastases in animals bearing primary tumours, since this approximates more closely to the clinical situation. In these experiments rats with primary hepatomata, induced by oral administration of 4-dimethylaminoazobenzene, have been examined for pulmonary metastases and the influence of intravenously administered B.C.G. on their development studied.
MATERIALS AND METHODS
Tumours. Primary hepatomata were induced by feeding adult male Wistar rats on a low protein diet containing 0 06% (w/w) 4-dimethylaminoazobenzene for 90 days (Baldwin, 1964) , after which they were returned to Oxoid cubed diet. Lungs were examined for metastases by perfusion with dilute India ink (Wexler, 1966) and the number of macroscopically detectable surface metastases counted with a x 10 stereoscopic microscope. The significance of the difference in incidence and numbers of metastases, between treated and control groups was calculated by the Wilcoxon non-parametric rank test. 
DISCUSSION
Previous studies have demonstrated that artificially produced or spontaneous metastases of transplanted rat tumours are suppressed by intravenous B.C.G. injection (Baldwin and Pimm, 1973a, b) . In these studies, however, conditions under which treatment was successful were not suitable models for a clinical situation. For example, in the production of artificial metastases by intravenous injection of tumour cells (Baldwin and Pimm, 1973a ) the number of cells and the time of initial entry into the lungs are known precisely and therefore are not comparable with the probable continued release of potentially metastatic cells from a growing primary tumour. Even with a rat epithelioma, where after subcutaneous graft excision intravenous B.C.G. reduces the numbers of metastases (Baldwin and Pimm, 1973b) , the initial tumour graft from which these metastases originated was present for only a few days. Neither of these experimental systems has allowed an evaluation of the influence of B.C.G. on metastases when the animal has an initial, localized, progressively growing tumour. The present studies extend these previous observations and demonstrate that pulmonary metastases from primary rat hepatomata can be significantly restricted by intravenous B.C.G. injection. In these tests, treatment had no influence on the occurrence of primary tumours or their growth rates as assessed from the survival of the animals. Most importantly, however, treatment of metastases was effective in the presence of primary tumours.
Clinically, suppression oftumour growth by contact with B.C.G. organisms has been achieved with surface tumours, particularly melanoma (Morton et al., 1970) , where intralesional infiltration of B.C.G. induces regression. Present and previous experimental studies suggest that tumour deposits at other sites, and particularly pulmonary metastases, might be controlled by infiltration of B.C.G. into the site of tumour or metastatic deposits. Moreover, it has recently been shown in a small number of cases that the survival of dogs with osteosarcoma is significantly increased if B.C.G. is administered intravenously post amputation of the affected limb (Owen et al., personal communication). However, toxic reactions to B.C.G. may result following intravenous administration. These include the formation of granulomatous lesions, particularly in the liver causing hepatic dysfunction, and a generalized systemic infection with B.C.G. organisms Hunt et al., 1973) . Non-living and non-toxic mycobacterial preparations will therefore be needed before B.C.G. could be used clinically, as described in the experimental situation in this paper. For treatment of transplanted rat tumours, B.C.G. sterilized by y irradiation retains suppressive properties both at local subcutaneous sites and for controlling pulmonary metastases (Baldwin et al., 1974) . In addition, B.C.G. cell walls attached to oil droplet emulsions can restrict localized tumours (Zbar, Rapp and Ribi, 1972) and the development of pulmonary metastases (Baldwin and Pimm, 1973d (Weiss, Bonhag and Leslie, 1966) and delipidated mycobacterial cell walls (Chedid et al., 1973) should be evaluated for this type of tumour suppressive property so that treatment of metastases, particularly in the lung, could be feasible clinically as well as in the type of experimental situation described in this paper.
